Skip to main content

AMIA’s goal is to improve the legislative and regulatory environment for health informatics research, practice and education through AMIA member expertise.  The primary pathway through which AMIA achieves this goal is by engaging Federal Agencies and Congress on public calls for input, such as Notices of Proposed Rulemakings (NPRMs) or Request for Information (RFIs).  Below, AMIA responses are arranged by Federal Agency and Congressional Committee.

Showing 1 - 10 out of 33

AMIA Supports More Research On Telemental Health

August 30, 2019

In response to a Request for Information from the National Institutes of Health (NIH), AMIA strongly supported additional research on whether telehealth can support initiatives related to suicide risk reduction and opioid overdose prevention. NIH was seeking input on current clinical experience in the use of telehealth in emergency department […]

AMIA Supports, Encourages Further Refinement of FDA AI/Machine Learning Regulatory Framework

June 5, 2019

In comments submitted this week to the U.S. Food and Drug Administration (FDA), the nation’s informatics professionals applauded the agency for developing a regulatory Modification Framework for Artificial Intelligence (AI)/Machine Learning (ML)-based software as a medical device (SaMD). The American Medical Informatics Association (AMIA) offered additional observations and recommendations for […]

AMIA Supports National Testing Collaborative for Health IT

December 20, 2018

In response to a Request for Information from the Centers for Disease Control and Prevention, AMIA urged HHS officials to focus on narrow use cases, such as CDS or eCQMs, when conceptualizing a national collaborative for health IT testing. AMIA also outlined the pros/cons of focusing on CDS versus eCQMs […]

AMIA Provides FDA Lit Review on Risk and Benefits of Medical Software

June 28, 2018

AMIA responded to an FDA request for input with a preliminary review of relevant research into the specific benefits and risks to health associated with software functions that the 21st Century Cures Act excluded from the definition of medical device. While some health IT applications to healthcare delivery have unambiguously […]